AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8815273 — intervention group
Group type: COMPARATOR
Intervention: Captopril (50 mg 1-2 times daily)
Number of subjects: 30
Study 2223740 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (1800 micrograms/d for more than 12 weeks)
Number of subjects: 450
Study 2223740 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation along with iron
Number of subjects: 450
Study 2223740 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 450
Study 6993706 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 3-g oral dose of amoxicillin trihydrate
Number of subjects: 134
Study 6993706 — intervention group
Group type: COMPARATOR
Intervention: Conventional ten-day courses of sulfamethoxazole-trimethoprim
Number of subjects: 134
Study 6993706 — intervention group
Group type: COMPARATOR
Intervention: Conventional ten-day courses of oral ampicillin sodium
Number of subjects: 134
Study 30084992 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (nCT)
Number of subjects: 181
Study 30084992 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 181
Study 30084992 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete histological response (TRG 1)
Number of subjects: 181
Study 30084992 — intervention group
Group type: EXPERIMENTAL
Intervention: No histological response (TRG 4)
Number of subjects: 181
Study 27649778 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg caffeine
Number of subjects: 82
Study 25873248 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 48
Study 25873248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 23381060 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapist-led psycho-educational intervention (two face-to-face consultations)
Number of subjects: 122
Study 23381060 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 122
Study 22017968 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine (30 mg)
Number of subjects: 22
Study 22017968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 19193781 — intervention group
Group type: COMPARATOR
Intervention: 400 mg/day imatinib
Number of subjects: 1692
Study 19193781 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg/day imatinib
Number of subjects: 1692
Study 19193781 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg/day imatinib after crossover
Number of subjects: 1692
Study 19193781 — intervention group
Group type: EXPERIMENTAL
Intervention: Both imatinib doses
Number of subjects: 1692
Study 17972452 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet gel (APG) and activated platelet-poor plasma (PPP) treatment
Number of subjects: 40
Study 17972452 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study 15458563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 11598595 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (10-minute circuit of varied jumping activities, 3 times per week for 7 months)
Number of subjects: 177
Study 11598595 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 177
Study 9562353 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion at 40 mU x m(‐2) x min(‐1) with 20% glucose to maintain euglycaemia
Number of subjects: 10
Study 9562353 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl infusion (control)
Number of subjects: 10
Study 8005834 — intervention group
Group type: EXPERIMENTAL
Intervention: Enterococcus faecium and Bifidobacterium longum (6.4 x 10(8) cfu d‐1)
Number of subjects: 24
Study 8005834 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus, Bif. bifidum, Lact. delbrueckii ssp. bulgaricus, and Streptococcus thermophilus (9 x 10(9) cfu d‐1)
Number of subjects: 24
Study 8005834 — intervention group
Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 24
Study 2509305 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetic acid jelly (A)
Number of subjects: 61
Study 2509305 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen cream (B)
Number of subjects: 61
Study 2509305 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk product (C)
Number of subjects: 61
Study 2509305 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (D)
Number of subjects: 61
Study 2509305 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study 183788 — intervention group
Group type: EXPERIMENTAL
Intervention: LF 178 (200 to 400 mg daily for 1 to 18 months)
Number of subjects: 191
Study 31121141 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive radical hysterectomy
Number of subjects: 0
Study 28502313 — intervention group
Group type: EXPERIMENTAL
Intervention: Klar bleiben program (intervention group)
Number of subjects: 4163
Study 28502313 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4163
Study 25440329 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg (group A)
Number of subjects: 240
Study 25440329 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg (group B)
Number of subjects: 240
Study 25440329 — intervention group
Group type: COMPARATOR
Intervention: No atorvastatin (group C)
Number of subjects: 240
Study 22107331 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 14
Study 21921413 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (2.5 mg/day increased to 10 mg/day)
Number of subjects: 104
Study 21921413 — intervention group
Group type: COMPARATOR
Intervention: Control (no rosuvastatin administered)
Number of subjects: 104
Study 20070012 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive cultural competence curriculum
Number of subjects: 109
Study 20070012 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 109
Study 17039216 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates therapy
Number of subjects: 53
Study 17039216 — intervention group
Group type: COMPARATOR
Intervention: Back School treatment
Number of subjects: 53
Study 14736842 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT(1A)R binding in PD patients
Number of subjects: 16
Study 14736842 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT(1A)R binding in PD patients with comorbid depression
Number of subjects: 16
Study 14736842 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 16
Study 11529534 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sedation with midazolam
Number of subjects: 62
Study 11529534 — intervention group
Group type: COMPARATOR
Intervention: Intranasal sedation with midazolam
Number of subjects: 62
Study 11529534 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy procedure
Number of subjects: 62
Study 11529534 — intervention group
Group type: COMPARATOR
Intervention: Comparison of sedation methods
Number of subjects: 62
Study 9101306 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors (ceronapril or delapril)
Number of subjects: 33
Study 9101306 — intervention group
Group type: COMPARATOR
Intervention: Calcium antagonists (nifedipine or nicardipine)
Number of subjects: 33
Study 8324671 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 81
Study 8324671 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 81
Study 3717762 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen therapy (PaO2, 69 +/- 4 mmHg)
Number of subjects: 10
Study 3717762 — intervention group
Group type: COMPARATOR
Intervention: Room air breathing (PaO2, 43 +/- 3 mmHg)
Number of subjects: 10
Study 31750018 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-methods approach to characterize verbal expression of feelings
Number of subjects: 1
Study 31750018 — intervention group
Group type: COMPARATOR
Intervention: Self-report checklists for emotional disorders (depression/anxiety)
Number of subjects: 1
Study 27625052 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated EBM training
Number of subjects: 79
Study 27625052 — intervention group
Group type: COMPARATOR
Intervention: Stand-alone EBM training
Number of subjects: 79
Study 24425125 — intervention group
Group type: EXPERIMENTAL
Intervention: Clazosentan for the prevention of angiographic vasospasm
Number of subjects: 120
Study 24425125 — intervention group
Group type: EXPERIMENTAL
Intervention: Aneurysm-securing procedure, subarachnoid clot clearance, and intracerebral hemorrhage
Number of subjects: 120
Study 24425125 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers of anemia and albumin levels
Number of subjects: 120
Study 23363676 — intervention group
Group type: EXPERIMENTAL
Intervention: Management group (trained community hospital doctors)
Number of subjects: 200
Study 23363676 — intervention group
Group type: COMPARATOR
Intervention: Control group (community doctors without special training)
Number of subjects: 200
Study 18801830 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 70
Study 18801830 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 70
Study 18061147 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment (SSRI) for 12 weeks
Number of subjects: 18
Study 15930193 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-safety counseling including firearm safety
Number of subjects: 76
Study 12805339 — intervention group
Group type: EXPERIMENTAL
Intervention: RSR13 plus cranial radiation therapy (30 Gy in 10 fractions of 3 Gy each), RSR13 dosage of 50 to 100 mg/kg intravenously over 30 minutes.
Number of subjects: 57
Study 12805339 — intervention group
Group type: EXPERIMENTAL
Intervention: RSR13 plus cranial radiation therapy (30 Gy in 10 fractions of 3 Gy each).
Number of subjects: 57
Study 12805339 — intervention group
Group type: COMPARATOR
Intervention: RTOG BMD patients (control group).
Number of subjects: 57
Study 12409685 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants (imipramine, phenelzine, L-deprenyl, mianserin, desipramine)
Number of subjects: 940
Study 12409685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 940
Study 9531406 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk deformity assessment using seven measures (shoulder-height difference, shoulder-angle asymmetry, decompensation, scapula asymmetry, waist crease, waist asymmetry, pelvic asymmetry)
Number of subjects: 20
Study 7921519 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg nicorandil
Number of subjects: 42
Study 7921519 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg nicorandil
Number of subjects: 42
Study 7921519 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nicorandil
Number of subjects: 42
Study 7921519 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nicorandil
Number of subjects: 42
Study 7921519 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg nicorandil
Number of subjects: 42
Study 7921519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 7921519 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of nicorandil
Number of subjects: 42
Study 3048155 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg, twice daily)
Number of subjects: 169
Study 3048155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study 31708151 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Number of subjects: 2018
Study 31708151 — intervention group
Group type: COMPARATOR
Intervention: Standard oral iron therapy
Number of subjects: 2018
Study 29103436 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) device used on one side of the maxillary arch for 7 hours on 3 consecutive nights.
Number of subjects: 33
Study 29103436 — intervention group
Group type: COMPARATOR
Intervention: Placebo PEMF device with inversely inserted battery used on the opposite side of the maxillary arch for 7 hours on 3 consecutive nights.
Number of subjects: 33
Study 26614143 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection dexmedetomidine 0.2 mcg/kg
Number of subjects: 60
Study 26614143 — intervention group
Group type: COMPARATOR
Intervention: Injection lignocaine 0.2 mg/kg
Number of subjects: 60
Study 22702490 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric citrate
Number of subjects: 0
Study 22702490 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 0
Study 22702490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21802079 — intervention group
Group type: EXPERIMENTAL
Intervention: Udenafil
Number of subjects: 278
Study 21802079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study 19633278 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telephone counseling (n = 769)
Number of subjects: 1562
Study 19633278 — intervention group
Group type: COMPARATOR
Intervention: Self-help materials (control: n = 793)
Number of subjects: 1562
Study 19633278 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telephone counseling
Number of subjects: 1562
Study 19633278 — intervention group
Group type: EXPERIMENTAL
Intervention: Active telephone recruitment
Number of subjects: 1562
Study 16933433 — intervention group
Group type: EXPERIMENTAL
Intervention: Family therapy
Number of subjects: 0
Study 16933433 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 15129059 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional restoration program
Number of subjects: 86
Study 15129059 — intervention group
Group type: COMPARATOR
Intervention: Active individual therapy (3 hours physical therapy per week for 5 weeks)
Number of subjects: 86
Study 11789860 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 50
Study 11789860 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 50
Study 9437275 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 10000
Study 9437275 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (high risk subgroup)
Number of subjects: 10000
Study 8270040 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial test with >= 5 squares positive
Number of subjects: 137
Study 8270040 — intervention group
Group type: COMPARATOR
Intervention: Initial test with < 5 squares positive
Number of subjects: 137
Study 3560070 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg metergoline
Number of subjects: 100
Study 3560070 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg metergoline
Number of subjects: 100
Study 3560070 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg bromoergocriptine
Number of subjects: 100
Study 3560070 — intervention group
Group type: COMPARATOR
Intervention: metergoline treatment on the fourth postpartum day
Number of subjects: 100
Study 3560070 — intervention group
Group type: COMPARATOR
Intervention: metergoline treatment on the eighth postpartum day
Number of subjects: 100
Study 3560070 — intervention group
Group type: COMPARATOR
Intervention: metergoline treatment with TRH stimulation
Number of subjects: 100
Study 3560070 — intervention group
Group type: COMPARATOR
Intervention: control group without metergoline treatment
Number of subjects: 100
Study 30709725 — intervention group
Group type: EXPERIMENTAL
Intervention: Med-Jet® H4
Number of subjects: 80
Study 30709725 — intervention group
Group type: COMPARATOR
Intervention: Needle injection
Number of subjects: 80
Study 28651515 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive corticosteroid treatment
Number of subjects: 3800
Study 28651515 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard SAP for the ADRENAL trial
Number of subjects: 3800
Study 28651515 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical comparisons between groups
Number of subjects: 3800
Study 25928627 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention including checklist, daily care goals, clinician prompting, and feedback on adherence rates.
Number of subjects: 118
Study 25928627 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group).
Number of subjects: 118
Study 25928627 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention.
Number of subjects: 118
Study 24298765 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Jing-well points on the differentiated meridians and temple-three-needle therapy
Number of subjects: 73
Study 24298765 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 73
Study 24298765 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 73
Study 20417055 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation (SIM) training
Number of subjects: 28
Study 20417055 — intervention group
Group type: COMPARATOR
Intervention: Didactic lecture (LEC)
Number of subjects: 28
Study 19909605 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam 10 mg oral dose 1-2 hours before embryo transfer
Number of subjects: 200
Study 19909605 — intervention group
Group type: COMPARATOR
Intervention: Control group (no piroxicam)
Number of subjects: 200
Study 16803675 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor
Number of subjects: 41
Study 16803675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 12953031 — intervention group
Group type: EXPERIMENTAL
Intervention: On-line convective treatments (HF and HDF)
Number of subjects: 0
Study 12953031 — intervention group
Group type: COMPARATOR
Intervention: Low-flux HD
Number of subjects: 0
Study 10651673 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotension group (sodium nitroprusside-induced controlled hypotension, mean arterial blood pressure adjusted to 50 mmHg)
Number of subjects: 30
Study 10651673 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotension group
Number of subjects: 30
Study 10651673 — intervention group
Group type: COMPARATOR
Intervention: Control group (mean arterial blood pressure > 70 mmHg)
Number of subjects: 30
Study 10651673 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 9339606 — intervention group
Group type: EXPERIMENTAL
Intervention: Legionella testing (culture, DFA, IIF, ELISA)
Number of subjects: 100
Study 9339606 — intervention group
Group type: COMPARATOR
Intervention: Environmental samples
Number of subjects: 100
Study 9339606 — intervention group
Group type: COMPARATOR
Intervention: Controls (age and sex matched)
Number of subjects: 100
Study 7678046 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary ferrous sulphate
Number of subjects: 50
Study 7678046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 7678046 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulphate
Number of subjects: 50
Study 3746904 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral visual acuity training program
Number of subjects: 20
Study 3746904 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 20
Study 29929894 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography combined with pressure waveform transduction
Number of subjects: 48
Study 29929894 — intervention group
Group type: COMPARATOR
Intervention: Pressure waveform transduction alone
Number of subjects: 48
Study 27923379 — intervention group
Group type: EXPERIMENTAL
Intervention: Reusable pads (AFRIpads)
Number of subjects: 205
Study 27923379 — intervention group
Group type: COMPARATOR
Intervention: Existing improvised methods (predominately new or old cloth)
Number of subjects: 205
Study 24090625 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline resilience
Number of subjects: 1090
Study 24090625 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in resilience (increased or decreased)
Number of subjects: 1090
Study 24090625 — intervention group
Group type: COMPARATOR
Intervention: Age, gender, educational attainment, combat exposure, PTSD symptom severity, self-reported alcohol abuse
Number of subjects: 1090
Study 24090625 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological resilience
Number of subjects: 1090
Study 23065392 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude methanolic extracts of Euphorbia helioscopia at concentrations of 12.5 mg/ml, 25 mg/ml, and 50 mg/ml
Number of subjects: 0
Study 23065392 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous extracts of Euphorbia helioscopia
Number of subjects: 0
Study 23065392 — intervention group
Group type: EXPERIMENTAL
Intervention: Methanolic and aqueous extracts of Euphorbia helioscopia at concentrations ranging from 100 to 500 mg/ml
Number of subjects: 0
Study 20848384 — intervention group
Group type: EXPERIMENTAL
Intervention: Illustration group (detailed illustrations regarding medication use)
Number of subjects: 65
Study 20848384 — intervention group
Group type: COMPARATOR
Intervention: Oral group (standard oral postoperative instructions)
Number of subjects: 65
Study 17365753 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 741
Study 17365753 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 741
Study 15478523 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine, 2 mg twice daily
Number of subjects: 10
Study 15478523 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine at self-selected doses (SSDs)
Number of subjects: 10
Study 15478523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15478523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin at self-selected doses (SSDs)
Number of subjects: 10
Study 11895302 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound (PD) in patients with enlarged, abnormal tendons
Number of subjects: 11
Study 11895302 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI and conventional ultrasound (US)
Number of subjects: 11
Study 11895302 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 11
Study 9627202 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 0
Study 9627202 — intervention group
Group type: COMPARATOR
Intervention: Lamotrigine (LTG)
Number of subjects: 0